 | • レポートコード：MRC2312MG05396 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、151ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥721,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の分子生物学実験器具市場規模と予測を収録しています。・世界の分子生物学実験器具市場：売上、2018年-2023年、2024年-2029年 ・世界の分子生物学実験器具市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の分子生物学実験器具市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「感染症」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 分子生物学実験器具のグローバル主要企業は、Seegene、 SPACEGEN、 VITASSAY HEALTHCARE S.L.、 Yaneng Bioscience (Shenzhen) Co., Ltd.、 Zhejiang Orient Gene、 ELITech Group、 Fujirebio、 Jiangsu Bioperfectus Technologies Co., Ltd.、 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.、 Altona Diagnostics GmbH、 NZYTech、 ATTOPLEX、 OSANG Healthcare、 Panagene Inc.、 PCRmax、 R-Biopharm AG、 AB Analitica、 Celnovte Biotechnology Co., Ltd.、 Elisabeth Pharmacon Spol、 Jiangsu Mole Bioscience CO., LTD.、 Medical Innovation Ventures、 Randox Laboratoriesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、分子生物学実験器具のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の分子生物学実験器具市場：タイプ別、2018年-2023年、2024年-2029年 世界の分子生物学実験器具市場：タイプ別市場シェア、2022年 ・感染症、呼吸器疾患、癌、遺伝子変異、消化器疾患、その他 世界の分子生物学実験器具市場：用途別、2018年-2023年、2024年-2029年 世界の分子生物学実験器具市場：用途別市場シェア、2022年 ・病院、診療所、研究所、その他 世界の分子生物学実験器具市場：地域・国別、2018年-2023年、2024年-2029年 世界の分子生物学実験器具市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における分子生物学実験器具のグローバル売上、2018年-2023年 ・主要企業における分子生物学実験器具のグローバル売上シェア、2022年 ・主要企業における分子生物学実験器具のグローバル販売量、2018年-2023年 ・主要企業における分子生物学実験器具のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Seegene、 SPACEGEN、 VITASSAY HEALTHCARE S.L.、 Yaneng Bioscience (Shenzhen) Co., Ltd.、 Zhejiang Orient Gene、 ELITech Group、 Fujirebio、 Jiangsu Bioperfectus Technologies Co., Ltd.、 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.、 Altona Diagnostics GmbH、 NZYTech、 ATTOPLEX、 OSANG Healthcare、 Panagene Inc.、 PCRmax、 R-Biopharm AG、 AB Analitica、 Celnovte Biotechnology Co., Ltd.、 Elisabeth Pharmacon Spol、 Jiangsu Mole Bioscience CO., LTD.、 Medical Innovation Ventures、 Randox Laboratories ************************************************************* ・調査・分析レポートの概要 分子生物学実験器具市場の定義 市場セグメント 世界の分子生物学実験器具市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の分子生物学実験器具市場規模 世界の分子生物学実験器具市場規模：2022年 VS 2029年 世界の分子生物学実験器具市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの分子生物学実験器具の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の分子生物学実験器具製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：感染症、呼吸器疾患、癌、遺伝子変異、消化器疾患、その他 分子生物学実験器具のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、研究所、その他 分子生物学実験器具の用途別グローバル売上・予測 ・地域別市場分析 地域別分子生物学実験器具市場規模 2022年と2029年 地域別分子生物学実験器具売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Seegene、 SPACEGEN、 VITASSAY HEALTHCARE S.L.、 Yaneng Bioscience (Shenzhen) Co., Ltd.、 Zhejiang Orient Gene、 ELITech Group、 Fujirebio、 Jiangsu Bioperfectus Technologies Co., Ltd.、 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.、 Altona Diagnostics GmbH、 NZYTech、 ATTOPLEX、 OSANG Healthcare、 Panagene Inc.、 PCRmax、 R-Biopharm AG、 AB Analitica、 Celnovte Biotechnology Co., Ltd.、 Elisabeth Pharmacon Spol、 Jiangsu Mole Bioscience CO., LTD.、 Medical Innovation Ventures、 Randox Laboratories ... |
This research report provides a comprehensive analysis of the Molecular Biology Experimental Instruments market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Molecular Biology Experimental Instruments market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Molecular Biology Experimental Instruments, challenges faced by the industry, and potential opportunities for market players.
The global Molecular Biology Experimental Instruments market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Molecular Biology Experimental Instruments market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Molecular Biology Experimental Instruments market. Additionally, the growing consumer demand present avenues for market expansion.
The global Molecular Biology Experimental Instruments market was valued at US$ 536.7 million in 2022 and is projected to reach US$ 766.9 million by 2029, at a CAGR of 5.6% during the forecast period.
The global medical device market is estimated to be US$603.3 billion in 2023, with a compound annual growth rate of 5% expected in the next six years. Global health care expenditure currently accounts for approximately 10% of global GDP, and the proportion will continue to increase in the next few years. This is primarily due to the increasing demand for healthcare from an aging population, the rising prevalence of chronic and infectious diseases, and the expansion of emerging markets. The medical device market plays an important role in the healthcare spending industry. The medical device market is driven by a variety of factors, including increasing global demand for advanced medical services, advancements in medical technology, growing geriatric population, increasing medical expenditures, and increasing awareness of early stage disease diagnosis and treatment.
Key Features:
The research report on the Molecular Biology Experimental Instruments market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Molecular Biology Experimental Instruments market.
Market Overview: The report provides a comprehensive overview of the Molecular Biology Experimental Instruments market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Infectious Disease, Respiratory Disease), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Molecular Biology Experimental Instruments market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Molecular Biology Experimental Instruments market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Molecular Biology Experimental Instruments market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Molecular Biology Experimental Instruments market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Molecular Biology Experimental Instruments market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Molecular Biology Experimental Instruments market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Molecular Biology Experimental Instruments, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Molecular Biology Experimental Instruments market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Molecular Biology Experimental Instruments market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Infectious Disease
Respiratory Disease
For Cancer
Gene Mutation
Gastrointestinal Disease
Others
Market segment by Application
Hospital
Clinic
Research Center
Others
Global Molecular Biology Experimental Instruments Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Seegene
SPACEGEN
VITASSAY HEALTHCARE S.L.
Yaneng Bioscience (Shenzhen) Co., Ltd.
Zhejiang Orient Gene
ELITech Group
Fujirebio
Jiangsu Bioperfectus Technologies Co., Ltd.
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
Altona Diagnostics GmbH
NZYTech
ATTOPLEX
OSANG Healthcare
Panagene Inc.
PCRmax
R-Biopharm AG
AB Analitica
Celnovte Biotechnology Co., Ltd.
Elisabeth Pharmacon Spol
Jiangsu Mole Bioscience CO., LTD.
Medical Innovation Ventures
Randox Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Biology Experimental Instruments, market overview.
Chapter 2: Global Molecular Biology Experimental Instruments market size in revenue.
Chapter 3: Detailed analysis of Molecular Biology Experimental Instruments company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Biology Experimental Instruments in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Molecular Biology Experimental Instruments Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Biology Experimental Instruments Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Biology Experimental Instruments Overall Market Size
2.1 Global Molecular Biology Experimental Instruments Market Size: 2022 VS 2029
2.2 Global Molecular Biology Experimental Instruments Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Biology Experimental Instruments Players in Global Market
3.2 Top Global Molecular Biology Experimental Instruments Companies Ranked by Revenue
3.3 Global Molecular Biology Experimental Instruments Revenue by Companies
3.4 Top 3 and Top 5 Molecular Biology Experimental Instruments Companies in Global Market, by Revenue in 2022
3.5 Global Companies Molecular Biology Experimental Instruments Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Biology Experimental Instruments Players in Global Market
3.6.1 List of Global Tier 1 Molecular Biology Experimental Instruments Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Biology Experimental Instruments Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Molecular Biology Experimental Instruments Market Size Markets, 2022 & 2029
4.1.2 Infectious Disease
4.1.3 Respiratory Disease
4.1.4 For Cancer
4.1.5 Gene Mutation
4.1.6 Gastrointestinal Disease
4.1.7 Others
4.2 By Type – Global Molecular Biology Experimental Instruments Revenue & Forecasts
4.2.1 By Type – Global Molecular Biology Experimental Instruments Revenue, 2018-2023
4.2.2 By Type – Global Molecular Biology Experimental Instruments Revenue, 2024-2029
4.2.3 By Type – Global Molecular Biology Experimental Instruments Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Molecular Biology Experimental Instruments Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Research Center
5.1.5 Others
5.2 By Application – Global Molecular Biology Experimental Instruments Revenue & Forecasts
5.2.1 By Application – Global Molecular Biology Experimental Instruments Revenue, 2018-2023
5.2.2 By Application – Global Molecular Biology Experimental Instruments Revenue, 2024-2029
5.2.3 By Application – Global Molecular Biology Experimental Instruments Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Molecular Biology Experimental Instruments Market Size, 2022 & 2029
6.2 By Region – Global Molecular Biology Experimental Instruments Revenue & Forecasts
6.2.1 By Region – Global Molecular Biology Experimental Instruments Revenue, 2018-2023
6.2.2 By Region – Global Molecular Biology Experimental Instruments Revenue, 2024-2029
6.2.3 By Region – Global Molecular Biology Experimental Instruments Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Molecular Biology Experimental Instruments Revenue, 2018-2029
6.3.2 US Molecular Biology Experimental Instruments Market Size, 2018-2029
6.3.3 Canada Molecular Biology Experimental Instruments Market Size, 2018-2029
6.3.4 Mexico Molecular Biology Experimental Instruments Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Molecular Biology Experimental Instruments Revenue, 2018-2029
6.4.2 Germany Molecular Biology Experimental Instruments Market Size, 2018-2029
6.4.3 France Molecular Biology Experimental Instruments Market Size, 2018-2029
6.4.4 U.K. Molecular Biology Experimental Instruments Market Size, 2018-2029
6.4.5 Italy Molecular Biology Experimental Instruments Market Size, 2018-2029
6.4.6 Russia Molecular Biology Experimental Instruments Market Size, 2018-2029
6.4.7 Nordic Countries Molecular Biology Experimental Instruments Market Size, 2018-2029
6.4.8 Benelux Molecular Biology Experimental Instruments Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Molecular Biology Experimental Instruments Revenue, 2018-2029
6.5.2 China Molecular Biology Experimental Instruments Market Size, 2018-2029
6.5.3 Japan Molecular Biology Experimental Instruments Market Size, 2018-2029
6.5.4 South Korea Molecular Biology Experimental Instruments Market Size, 2018-2029
6.5.5 Southeast Asia Molecular Biology Experimental Instruments Market Size, 2018-2029
6.5.6 India Molecular Biology Experimental Instruments Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Molecular Biology Experimental Instruments Revenue, 2018-2029
6.6.2 Brazil Molecular Biology Experimental Instruments Market Size, 2018-2029
6.6.3 Argentina Molecular Biology Experimental Instruments Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Molecular Biology Experimental Instruments Revenue, 2018-2029
6.7.2 Turkey Molecular Biology Experimental Instruments Market Size, 2018-2029
6.7.3 Israel Molecular Biology Experimental Instruments Market Size, 2018-2029
6.7.4 Saudi Arabia Molecular Biology Experimental Instruments Market Size, 2018-2029
6.7.5 UAE Molecular Biology Experimental Instruments Market Size, 2018-2029
7 Molecular Biology Experimental Instruments Companies Profiles
7.1 Seegene
7.1.1 Seegene Company Summary
7.1.2 Seegene Business Overview
7.1.3 Seegene Molecular Biology Experimental Instruments Major Product Offerings
7.1.4 Seegene Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.1.5 Seegene Key News & Latest Developments
7.2 SPACEGEN
7.2.1 SPACEGEN Company Summary
7.2.2 SPACEGEN Business Overview
7.2.3 SPACEGEN Molecular Biology Experimental Instruments Major Product Offerings
7.2.4 SPACEGEN Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.2.5 SPACEGEN Key News & Latest Developments
7.3 VITASSAY HEALTHCARE S.L.
7.3.1 VITASSAY HEALTHCARE S.L. Company Summary
7.3.2 VITASSAY HEALTHCARE S.L. Business Overview
7.3.3 VITASSAY HEALTHCARE S.L. Molecular Biology Experimental Instruments Major Product Offerings
7.3.4 VITASSAY HEALTHCARE S.L. Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.3.5 VITASSAY HEALTHCARE S.L. Key News & Latest Developments
7.4 Yaneng Bioscience (Shenzhen) Co., Ltd.
7.4.1 Yaneng Bioscience (Shenzhen) Co., Ltd. Company Summary
7.4.2 Yaneng Bioscience (Shenzhen) Co., Ltd. Business Overview
7.4.3 Yaneng Bioscience (Shenzhen) Co., Ltd. Molecular Biology Experimental Instruments Major Product Offerings
7.4.4 Yaneng Bioscience (Shenzhen) Co., Ltd. Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.4.5 Yaneng Bioscience (Shenzhen) Co., Ltd. Key News & Latest Developments
7.5 Zhejiang Orient Gene
7.5.1 Zhejiang Orient Gene Company Summary
7.5.2 Zhejiang Orient Gene Business Overview
7.5.3 Zhejiang Orient Gene Molecular Biology Experimental Instruments Major Product Offerings
7.5.4 Zhejiang Orient Gene Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.5.5 Zhejiang Orient Gene Key News & Latest Developments
7.6 ELITech Group
7.6.1 ELITech Group Company Summary
7.6.2 ELITech Group Business Overview
7.6.3 ELITech Group Molecular Biology Experimental Instruments Major Product Offerings
7.6.4 ELITech Group Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.6.5 ELITech Group Key News & Latest Developments
7.7 Fujirebio
7.7.1 Fujirebio Company Summary
7.7.2 Fujirebio Business Overview
7.7.3 Fujirebio Molecular Biology Experimental Instruments Major Product Offerings
7.7.4 Fujirebio Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.7.5 Fujirebio Key News & Latest Developments
7.8 Jiangsu Bioperfectus Technologies Co., Ltd.
7.8.1 Jiangsu Bioperfectus Technologies Co., Ltd. Company Summary
7.8.2 Jiangsu Bioperfectus Technologies Co., Ltd. Business Overview
7.8.3 Jiangsu Bioperfectus Technologies Co., Ltd. Molecular Biology Experimental Instruments Major Product Offerings
7.8.4 Jiangsu Bioperfectus Technologies Co., Ltd. Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.8.5 Jiangsu Bioperfectus Technologies Co., Ltd. Key News & Latest Developments
7.9 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
7.9.1 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Company Summary
7.9.2 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Business Overview
7.9.3 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Molecular Biology Experimental Instruments Major Product Offerings
7.9.4 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.9.5 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Key News & Latest Developments
7.10 Altona Diagnostics GmbH
7.10.1 Altona Diagnostics GmbH Company Summary
7.10.2 Altona Diagnostics GmbH Business Overview
7.10.3 Altona Diagnostics GmbH Molecular Biology Experimental Instruments Major Product Offerings
7.10.4 Altona Diagnostics GmbH Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.10.5 Altona Diagnostics GmbH Key News & Latest Developments
7.11 NZYTech
7.11.1 NZYTech Company Summary
7.11.2 NZYTech Business Overview
7.11.3 NZYTech Molecular Biology Experimental Instruments Major Product Offerings
7.11.4 NZYTech Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.11.5 NZYTech Key News & Latest Developments
7.12 ATTOPLEX
7.12.1 ATTOPLEX Company Summary
7.12.2 ATTOPLEX Business Overview
7.12.3 ATTOPLEX Molecular Biology Experimental Instruments Major Product Offerings
7.12.4 ATTOPLEX Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.12.5 ATTOPLEX Key News & Latest Developments
7.13 OSANG Healthcare
7.13.1 OSANG Healthcare Company Summary
7.13.2 OSANG Healthcare Business Overview
7.13.3 OSANG Healthcare Molecular Biology Experimental Instruments Major Product Offerings
7.13.4 OSANG Healthcare Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.13.5 OSANG Healthcare Key News & Latest Developments
7.14 Panagene Inc.
7.14.1 Panagene Inc. Company Summary
7.14.2 Panagene Inc. Business Overview
7.14.3 Panagene Inc. Molecular Biology Experimental Instruments Major Product Offerings
7.14.4 Panagene Inc. Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.14.5 Panagene Inc. Key News & Latest Developments
7.15 PCRmax
7.15.1 PCRmax Company Summary
7.15.2 PCRmax Business Overview
7.15.3 PCRmax Molecular Biology Experimental Instruments Major Product Offerings
7.15.4 PCRmax Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.15.5 PCRmax Key News & Latest Developments
7.16 R-Biopharm AG
7.16.1 R-Biopharm AG Company Summary
7.16.2 R-Biopharm AG Business Overview
7.16.3 R-Biopharm AG Molecular Biology Experimental Instruments Major Product Offerings
7.16.4 R-Biopharm AG Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.16.5 R-Biopharm AG Key News & Latest Developments
7.17 AB Analitica
7.17.1 AB Analitica Company Summary
7.17.2 AB Analitica Business Overview
7.17.3 AB Analitica Molecular Biology Experimental Instruments Major Product Offerings
7.17.4 AB Analitica Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.17.5 AB Analitica Key News & Latest Developments
7.18 Celnovte Biotechnology Co., Ltd.
7.18.1 Celnovte Biotechnology Co., Ltd. Company Summary
7.18.2 Celnovte Biotechnology Co., Ltd. Business Overview
7.18.3 Celnovte Biotechnology Co., Ltd. Molecular Biology Experimental Instruments Major Product Offerings
7.18.4 Celnovte Biotechnology Co., Ltd. Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.18.5 Celnovte Biotechnology Co., Ltd. Key News & Latest Developments
7.19 Elisabeth Pharmacon Spol
7.19.1 Elisabeth Pharmacon Spol Company Summary
7.19.2 Elisabeth Pharmacon Spol Business Overview
7.19.3 Elisabeth Pharmacon Spol Molecular Biology Experimental Instruments Major Product Offerings
7.19.4 Elisabeth Pharmacon Spol Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.19.5 Elisabeth Pharmacon Spol Key News & Latest Developments
7.20 Jiangsu Mole Bioscience CO., LTD.
7.20.1 Jiangsu Mole Bioscience CO., LTD. Company Summary
7.20.2 Jiangsu Mole Bioscience CO., LTD. Business Overview
7.20.3 Jiangsu Mole Bioscience CO., LTD. Molecular Biology Experimental Instruments Major Product Offerings
7.20.4 Jiangsu Mole Bioscience CO., LTD. Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.20.5 Jiangsu Mole Bioscience CO., LTD. Key News & Latest Developments
7.21 Medical Innovation Ventures
7.21.1 Medical Innovation Ventures Company Summary
7.21.2 Medical Innovation Ventures Business Overview
7.21.3 Medical Innovation Ventures Molecular Biology Experimental Instruments Major Product Offerings
7.21.4 Medical Innovation Ventures Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.21.5 Medical Innovation Ventures Key News & Latest Developments
7.22 Randox Laboratories
7.22.1 Randox Laboratories Company Summary
7.22.2 Randox Laboratories Business Overview
7.22.3 Randox Laboratories Molecular Biology Experimental Instruments Major Product Offerings
7.22.4 Randox Laboratories Molecular Biology Experimental Instruments Revenue in Global Market (2018-2023)
7.22.5 Randox Laboratories Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer